Volume 19, Number 11—November 2013
CME ACTIVITY - Research
Possible Association between Obesity and Clostridium difficile Infection
Table 1
Characteristic | Community onset n = 59 | Community-onset health care–associated n = 32 | Health care onset n = 41 | p value |
---|---|---|---|---|
Demographic traits | ||||
Mean age [range] | 57.8 [22–96] | 63.7 [23–95] | 61.6 [21–96] | 0.31* |
Male sex, no. (%) | 27 (46) | 10 (31) | 23 (56) | 0.106 |
Medication use, no. (%) | ||||
Prior antibiotic use | 31 (52.5) | 11 (34.4) | 33 (80) | <0.001 |
Antiulcer medication | 24 (41) | 18 (56) | 19 (46) | 0.363 |
Physical status/illness, no. (%) | ||||
Obese (body mass index>30) | 20 (34) | 4 (13) | 13 (32) | 0.078 |
Immunocompromised† | 14 (24) | 11 (34) | 11 (27) | 0.551 |
Diabetes | 14 (24) | 9 (28) | 7 (17) | 0.519 |
Irritable bowel disease | 10 (17) | 1 (3) | 1 (2) | 0.018 |
Required inpatient admission, no. (%) | 41 (69) | 29 (91) | 39 (95) | 0.002 |
Average days stayed | 7.7 | 8.2 | 18.6 | <0.001 |
Required intensive care unit stay | 11 (27) | 8 (28) | 24 (61) | 0.002 |
*P value for 1-way analysis of variance.
†Immunocomprised group included all malignancies, innate and acquired immune conditions such as HIV/AIDS, and congenital immune defects. This group excluded comorbidities listed separately.
Page created: November 06, 2013
Page updated: November 06, 2013
Page reviewed: November 06, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.